Cargando…

Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?

SIMPLE SUMMARY: Ductal carcinoma in situ (DCIS) is an early-stage breast cancer (BC), in which tumor cells are growing in a localized duct of the mammary gland. DCIS is considered a precursor disease for invasive BC and, therefore, treated as soon as it is identified. However, low-grade DCIS can be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kothari, Charu, Clemenceau, Alisson, Ouellette, Geneviève, Ennour-Idrissi, Kaoutar, Michaud, Annick, Diorio, Caroline, Durocher, Francine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038727/ https://www.ncbi.nlm.nih.gov/pubmed/33917306 http://dx.doi.org/10.3390/cancers13071726

Ejemplares similares

TBC1D9: An Important Modulator of Tumorigenesis in Breast Cancer
por: Kothari, Charu, et al.
Publicado: (2021)

Secreted Frizzled-Related Protein 1 as a Biomarker against Incomplete Age-Related Lobular Involution and Microcalcifications’ Development
por: Clemenceau, Alisson, et al.
Publicado: (2020)

An isoform of AIF1 involved in breast cancer
por: Slim, Ferial Amira, et al.
Publicado: (2018)

Epigenome-wide DNA methylation and risk of breast cancer: a systematic review
por: Ennour-Idrissi, Kaoutar, et al.
Publicado: (2020)

Role of Secreted Frizzled-Related Protein 1 in Early Breast Carcinogenesis and Breast Cancer Aggressiveness
por: Clemenceau, Alisson, et al.
Publicado: (2023)

DNA Methylation and Breast Cancer Risk: An Epigenome-Wide Study of Normal Breast Tissue and Blood
por: Ennour-Idrissi, Kaoutar, et al.
Publicado: (2020)

Role of Secreted Frizzled-Related Protein 1 in Early Mammary Gland Tumorigenesis and Its Regulation in Breast Microenvironment
por: Clemenceau, Alisson, et al.
Publicado: (2020)

Association of Breast Tumour Expression of Cannabinoid Receptors CBR1 and CBR2 with Prognostic Factors and Survival in Breast Cancer Patients
por: Morin-Buote, Jessica, et al.
Publicado: (2021)

Breast Cancer and Microcalcifications: An Osteoimmunological Disorder?
por: Clemenceau, Alisson, et al.
Publicado: (2020)

Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy
por: Kothari, Charu, et al.
Publicado: (2018)

Effect of physical activity on sex hormones in women: a systematic review and meta-analysis of randomized controlled trials
por: Ennour-Idrissi, Kaoutar, et al.
Publicado: (2015)

Persistent Organic Pollutants and Breast Cancer: A Systematic Review and Critical Appraisal of the Literature
por: Ennour-Idrissi, Kaoutar, et al.
Publicado: (2019)

The Importance of Breast Adipose Tissue in Breast Cancer
por: Kothari, Charu, et al.
Publicado: (2020)

Association of Telomere Length with Breast Cancer Prognostic Factors
por: Ennour-Idrissi, Kaoutar, et al.
Publicado: (2016)

Machine learning analysis identifies genes differentiating triple negative breast cancers
por: Kothari, Charu, et al.
Publicado: (2020)

Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines
por: Burguin, Anna, et al.
Publicado: (2020)

Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments
por: Burguin, Anna, et al.
Publicado: (2023)

Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families
por: Pouliot, Marie-Christine, et al.
Publicado: (2017)

Knockdown of CKAP2 Inhibits Proliferation, Migration, and Aggregate Formation in Aggressive Breast Cancer
por: dos Santos, Alexsandro, et al.
Publicado: (2022)

Breast Cancer Treatments: Updates and New Challenges
por: Burguin, Anna, et al.
Publicado: (2021)

CARBOXYPEPTIDASE : III. THE ESTIMATION OF CARBOXYPEPTIDASE AND PRO-CARBOXYPEPTIDASE
por: Anson, M. L.
Publicado: (1937)

Adiposity, breast density, and breast cancer risk: epidemiological and biological considerations
por: Soguel, Ludivine, et al.
Publicado: (2017)

CARBOXYPEPTIDASE : I. THE PREPARATION OF CRYSTALLINE CARBOXYPEPTIDASE
por: Anson, M. L.
Publicado: (1937)

Associations of Biomarkers of Inflammation and Breast Cancer in the Breast Adipose Tissue of Women with Combined Measures of Adiposity
por: Chang, Sue-Ling, et al.
Publicado: (2021)

CARBOXYPEPTIDASE : II. THE PARTIAL PURIFICATION OF PRO-CARBOXYPEPTIDASE
por: Anson, M. L.
Publicado: (1937)

Label-Free Quantitative Proteomics Unravels Carboxypeptidases as the Novel Biomarker in Pancreatic Ductal Adenocarcinoma
por: Song, Yang, et al.
Publicado: (2018)

Prognostic significance of carboxypeptidase Q and its methylation in glioblastoma
por: Liu, Qiaodan, et al.
Publicado: (2023)

Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer
por: Desjardins, Sylvie, et al.
Publicado: (2009)

The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
por: Toss, Michael S., et al.
Publicado: (2020)

Diagnostic and Prognostic Significance of Carboxypeptidase A4 (CPA4) in Breast Cancer
por: Bademler, Suleyman, et al.
Publicado: (2019)

Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma
por: Xu, Ting, et al.
Publicado: (2022)

Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma
por: Chen, Dafu, et al.
Publicado: (2023)

The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ
por: Gilleard, Onur, et al.
Publicado: (2008)

Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ
por: Xu, Fei-Fei, et al.
Publicado: (2021)

Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ()
por: Darvishian, Farbod, et al.
Publicado: (2022)

Exploration of the breast ductal carcinoma in situ signature and its prognostic implications
por: Zhang, Jiao, et al.
Publicado: (2022)

Glutamate carboxypeptidase activity in human skin biopsies as a pharmacodynamic marker for clinical studies
por: Rojas, Camilo, et al.
Publicado: (2011)

Measurement of carboxypeptidase R by colorimetric assay
por: Komura, H, et al.
Publicado: (2002)

Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (Activated Thrombin-activable Fibrinolysis Inhibitor), and Platelets
por: Du, Xiao-Yan, et al.
Publicado: (2009)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_qd0ao7v22ppc2d8t83k9esngh2